Kairos Share Price
AMEX: KAPA | Micro Cap | Healthcare$0.42
+$0.42 (--%) Last updated on 21 Nov, 2026 | 02:23 ISTKairos Stock Performance
Kairos Share Price Chart
$0.45$0.45
L
H
Kairos Quarterly Profit & Loss
All figures in USD
Kairos Annual Profit & Loss
All figures in USD
Kairos Balance Sheet
All figures in USD Million
Kairos Cash Flow
Annually
Corporate Actions
About Kairos
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Kairos Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.53 | $0.45 | -15.37% |
Oct 2026 | $1.55 | $0.53 | -68.63% |
Sep 2026 | $1.59 | $1.68 | +594.21% |
Aug 2026 | $0.30 | $0.24 | -22.68% |
Jul 2026 | $0.37 | $0.31 | -19.74% |
Jun 2026 | $0.50 | $0.39 | -22.16% |
May 2026 | $0.56 | $0.50 | -12.11% |
Apr 2026 | $0.55 | $0.57 | +1.60% |
Mar 2026 | $0.62 | $0.56 | -8.18% |
Feb 2026 | $0.68 | $0.61 | -10.15% |
Jan 2026 | $0.72 | $0.68 | -4.36% |
Dec 2025 | $0.79 | $0.71 | -5.07% |